• Hospital for Special Surgery presented three studies on improving rheumatoid arthritis treatment selection at ACR Convergence 2026 in Orlando, Florida.
• Synovial fluid findings suggest joint fluid could offer a less invasive alternative to tissue biopsies for assessing inflammation.
• Fluid protein patterns distinguished high from low tissue inflammation, potentially supporting more personalized treatment decisions.
• Higher fluid inflammation was associated with elevated blood inflammatory markers and subsequent medication changes, but did not correlate with patient-reported pain.
• Ultrasound findings varied by joint location and disease stage, affecting how well scans reflected underlying tissue inflammation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HSS - Hospital for Special Surgery published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.